Corrigendum to "A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases" [Vaccine 42 (12) (2024) 3039-3048]
Vaccine. 2024 Oct 12:126438.
doi: 10.1016/j.vaccine.2024.126438.
Online ahead of print.
1 Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: [email protected].
2 Department of Data Science and Biostatistics, University Medical Centre Utrecht, Utrecht, The Netherlands.
3 Agenzia Regionale di Sanità (ARS), Florence, Toscana, Italy.
4 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
5 Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Valencia, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.
6 Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
7 Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
8 Teamit Institute, Partnerships, Barcelona Health Hub, Barcelona, Spain.
9 Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.